5-Amino-1MQ
5-Amino-1MQ is a weight management peptide used in evidence-based, physician-supervised protocols. Use for metabolically resistant fat (visceral, subcutaneous) that does not respond to GLP-1 alone.
What is 5-Amino-1MQ?
NNMT (nicotinamide N-methyltransferase) inhibitor. Blocks NNMT activity in adipocytes, raising intracellular SAM and NAD+ levels, activating SIRT1/AMPK, promoting fat cell browning and thermogenesis. Targets resistant fat depots.
Uses & clinical decision logic
Use for metabolically resistant fat (visceral, subcutaneous) that does not respond to GLP-1 alone. Run 2-4 week cycles — continuous use may reduce efficacy.
5-Amino-1MQ dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 1mL | 5-10mg | 100-200 units | 1-3x/week | SubQ |
| 10mg | 2mL | 5-10mg | 100-200 units | 1-3x/week | SubQ |
Safety & contraindications
Limited long-term human data — use conservatively.
Stacking & combinations
Synergistic with GLP-1 agents (complementary mechanisms); pairs well with SLU-PP-332 and NAD+.
Related peptides
Frequently asked questions
What is 5-Amino-1MQ used for?
Use for metabolically resistant fat (visceral, subcutaneous) that does not respond to GLP-1 alone. Run 2-4 week cycles — continuous use may reduce efficacy.
What is the typical 5-Amino-1MQ dosage?
Common dosing ranges from 5-10mg (1-3x/week, SubQ). Exact dosing is individualized and set by a licensed physician.
How is 5-Amino-1MQ administered?
5-Amino-1MQ is typically administered via SubQ.
What are the contraindications for 5-Amino-1MQ?
Limited long-term human data — use conservatively.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.